|
|
|
Volumn 48, Issue 1, 2000, Pages 16-20
|
|
The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
LACTONE;
MEMBRANE PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
PYRAZOLE DERIVATIVE;
ROFECOXIB;
SULFONAMIDE;
SULFONE;
WARFARIN;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
COMPARATIVE STUDY;
DRUG ANTAGONISM;
DRUG INTERACTION;
FACE PAIN;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
POSTOPERATIVE PAIN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG INTERACTIONS;
FACIAL PAIN;
GASTROINTESTINAL HEMORRHAGE;
HUMANS;
ISOENZYMES;
LACTONES;
MEMBRANE PROTEINS;
PAIN, POSTOPERATIVE;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
SULFONAMIDES;
SULFONES;
WARFARIN;
|
|
EID: 0033749989
PISSN: 03636771
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
